TABLE 2.
Patient characteristics1
| Demographics | Frequency, n (%) |
|---|---|
| Sex | |
| Male | 30 (47.6) |
| Female | 33 (52.4) |
| Age, y | |
| <70 | 21 (33.3) |
| ≥70 | 42 (66.7) |
| Ethnicity | |
| White | 59 (93.7) |
| Other | 4 (6.3) |
| BMI, kg/m2 | |
| ≥25 | 31 (49.2) |
| ≥30 | 15 (23.8) |
| Smoking status | |
| Current | 10 (15.9) |
| Ex | 28 (44.4) |
| Never | 25 (39.7) |
| Alcohol excess history | |
| Yes | 11 (17.5) |
| No | 52 (82.5) |
| Clinical frailty | |
| Yes | 45 (71.4) |
| No | 16 (25.4) |
| Not recorded | 2 (3.2) |
| Comorbidities | |
| Liver disease | |
| Yes | 6 (9.5) |
| No | 57 (90.5) |
| Hypertension | |
| Yes | 34 (53.1) |
| No | 29 (45.3) |
| Heart failure | |
| Yes | 8 (12.7) |
| No | 55 (87.3) |
| T2DM | |
| Yes | 18 (28.1) |
| No | 45 (70.3) |
| Chronic renal failure | |
| Yes | 11 (17.5) |
| No | 52 (82.5) |
| Asthma | |
| Yes | 13 (20.6) |
| No | 50 (79.4) |
| COPD | |
| Yes | 14 (22.2) |
| No | 49 (77.8) |
| Active cancer | |
| Yes | 11 (17.5) |
| No | 52 (82.5) |
| CT imaging | |
| Thorax, abdomen, and pelvis | 48 (76.2) |
| Abdomen and pelvis only | 15 (23.8) |
| Inflammatory status | |
| CRP, mg/L | |
| ≥10 | 52 (82.5) |
| ≥80 | 31 (49.2) |
| ≥150 | 14 (22.2) |
| Albumin, g/L | |
| <25 | 13 (20.6) |
| ≥25 | 50 (79.4) |
| NLR | |
| <3 | 10 (15.6) |
| 3–5 | 12 (18.8) |
| >5 | 41 (64.1) |
| poGPS | |
| 0 | 41 (65.1) |
| 1–2 | 22 (34.9) |
| Primary outcomes | |
| ITU admission | |
| Yes | 3 (4.8) |
| No | 60 (95.2) |
| 30-d mortality | |
| Yes | 11 (17.5) |
| No | 52 (82.5) |
1COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; CT, computed tomography; ITU, intensive therapy or care unit; NLR, neutrophil:lymphocyte ratio; poGPS, perioperative Glasgow Prognostic Score; T2DM, type 2 diabetes mellitus.